FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Jun 18, 2025
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on June 18, 2025, issued by the Philadelphia District Office, covering biologics.
- Person
View Company Profile
ID · 4d429e5b-bbcf-4e23-9e7e-3b86813807e6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1273078
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 640.64(e)Prevention of contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 20, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 7, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 30, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 3, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1080686 - 2019-02-07
- FDA Inspection 993528 - 2016-10-20
- FDA Inspection 902871 - 2014-11-07
- FDA Inspection 796710 - 2012-08-30
- FDA Inspection 678918 - 2010-09-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.